Loading
Histone Deacetylase Inhibitors Research / Protease and Inhibitor Mechanisms · Journal article
European Journal of Medical Research · August 18, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is an exploratory preclinical study showing that MTAP knockdown enhances proliferation and migration in lung cancer cell lines and increases bone metastasis incidence in mouse models, with observational association between MTAP deletion and poor survival in patient databases. The work is mechanistic and hypothesis-generating, identifying signal transduction and immune pathway alterations as potential mediators, but does not provide evidence ready for clinical translation.
Experimental study combining database analysis, in vitro cell line knockdown, and in vivo mouse models. Lung cancer patients from public databases (adenocarcinoma and squamous cell carcinoma); PC9 lung adenocarcinoma cell line; mouse models. Intervention: MTAP gene knockdown via lentiviral technology. Compared with: Parental (wild-type) PC9 cells and untreated mouse controls (inferred but not explicitly stated).
MTAP deletion associated with poor survival in lung cancer: p=0.032 for squamous cell carcinoma, p=0.039 for adenocarcinoma In vitro MTAP knockdown enhanced PC9 cell proliferation and migration In vivo MTAP knockdown increased incidence of bone metastasis in mouse models
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
This work does not directly inform current clinical practice but identifies MTAP as a potential therapeutic target warrant further investigation. Clinicians should await validation studies in human cohorts and mechanistic confirmation before considering MTAP status in treatment decisions.
Early-stage mechanistic study combining public database analysis, cell line knockdown, and mouse models with surrogate endpoints (proliferation, migration, bone metastasis incidence) but lacking human clinical validation of the proposed pathway.
As stated by the source record.
Quoted from the source exactly as published.
This work does not directly inform current clinical practice but identifies MTAP as a potential therapeutic target warrant further investigation. Clinicians should await validation studies in human cohorts and mechanistic confirmation before considering MTAP status in treatment decisions.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
Lung cancer continues to be the leading cause of cancer-related death worldwide. The advent of molecular targeted therapies has significantly changed the treatment landscape. Therefore, identifying new molecular targets is essential for the development of more effective treatment strategies. In this study, we first accessed publicly available databases to obtain datasets and information related to MTAP. We then used lentiviral technology to knock down the MTAP gene and examined how this knockdown affects cell proliferation and migration using both in vitro and in vivo experimental approaches. MTAP deletion is commonly observed in various types of cancer. In lung cancer patients, MTAP deletion was associated with poor survival outcomes, with p values of 0.032 for squamous cell carcinoma and 0.039 for adenocarcinoma. In vitro experiments revealed that MTAP deletion enhanced the proliferation and migration of PC9 cells. Further in vivo studies demonstrated that MTAP knockdown was associated with an increased incidence of bone metastasis in mouse models. RNA sequencing analysis comparing MTAP -knockdown and parental PC9 cell lines revealed significant differences in gene expression. KEGG pathway analysis of the differentially expressed genes revealed enrichment in pathways related to signal transduction and the immune system. MTAP deletion is frequently observed across a wide range of cancers. In lung cancer patients, MTAP deletion is associated with poorer overall survival. Evidence from our study suggests that alterations in signal transduction and immune system pathways may play a role in the increased rate of bone metastasis observed in mouse models with MTAP deletion.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.